History

2024
  • Analysis Technology Research Institute Relocation to Munjeong-dong, Seoul


  • Selection for the Korea Drug Development Fund (KDDF) project

  • Selection for the Korea Dementia Research Center project

2023
  • Expand Research facility (Analytical technology research center) in Institut Pasteur Korea (Pan-gyo, Korea)


  • Initiated the collaborative research with University of Cagliari

2022
  • Published a scientific paper on the therapeutic effect of 3,6'-DP in AD model with NIH (Alzheimer’s & Dementia, IF: 21.566)


  • Initiated the collaborative research with KRICT

2021
  • Chemical Research Center founded at Institut Pasteur Korea, Pan-gyo, Korea


  • Patent license agreement with NIH


  • Series A Investment


  • AevisBio entered into collaborative research with NCI, SEVERANCE, IPK, NIST

2020
  • Angel investment

  • Published a scientific paper on the therapeutic effect of 3,6'-DP in TBI model with NIH (eLife, IF: 8.14)

2019
  • AevisBio, Inc. founded in Gaithersburg, MD USA

  • Korean Government grant (post-TIPS) awarded

  • AevisBio entered into a CRADA with the NIA/NIH

  • Life Science research Center founded at KRIBB, Daejeon, Korea

2018
  • Aevis Bio, Inc. founded